205 related articles for article (PubMed ID: 34462790)
1. Investigating ultra-low-dose total-body [18F]-FDG PET/CT in colorectal cancer: initial experience.
Tan H; Cai D; Sui X; Qi C; Mao W; Zhang Y; Liu G; Yu H; Chen S; Hu P; Gu J; Shi H
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):1002-1011. PubMed ID: 34462790
[TBL] [Abstract][Full Text] [Related]
2. Half-dose versus full-dose 18 F-FDG total-body PET/CT in patients with colorectal cancer.
Tan H; Mao W; Cao Y; Cai D; Sui X; Qi C; Yu H; Zhang Y; Shi H
Nucl Med Commun; 2022 Aug; 43(8):928-936. PubMed ID: 35634804
[TBL] [Abstract][Full Text] [Related]
3. Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer.
Tan H; Sui X; Yin H; Yu H; Gu Y; Chen S; Hu P; Mao W; Shi H
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1966-1975. PubMed ID: 33244618
[TBL] [Abstract][Full Text] [Related]
4. Head-to-head intra-individual comparison of total-body 2-[
Chen X; Hu P; Yu H; Tan H; He Y; Cao S; Zhou Y; Shi H
Eur Radiol; 2023 Nov; 33(11):7890-7898. PubMed ID: 37338551
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of total-body
Hu Y; Liu G; Yu H; Gu J; Shi H
Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3538-3546. PubMed ID: 35344063
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low
Hu Y; Liu G; Yu H; Wang Y; Li C; Tan H; Chen S; Gu J; Shi H
J Nucl Med; 2022 Jun; 63(6):959-965. PubMed ID: 34593593
[TBL] [Abstract][Full Text] [Related]
7. Comparison of imaging protocols for 18F-FDG PET/CT in overweight patients: optimizing scan duration versus administered dose.
Masuda Y; Kondo C; Matsuo Y; Uetani M; Kusakabe K
J Nucl Med; 2009 Jun; 50(6):844-8. PubMed ID: 19443586
[TBL] [Abstract][Full Text] [Related]
8. Optimizing acquisition times for total-body positron emission tomography/computed tomography with half-dose
He Y; Gu Y; Yu H; Wu B; Wang S; Tan H; Cao Y; Chen S; Sui X; Zhang Y; Shi H
EJNMMI Phys; 2022 Jul; 9(1):45. PubMed ID: 35802280
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of pediatric malignancies using total-body PET/CT with half-dose [
Chen W; Liu L; Li Y; Li S; Li Z; Zhang W; Zhang X; Wu R; Hu D; Sun H; Zhou Y; Fan W; Zhao Y; Zhang Y; Hu Y
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4145-4155. PubMed ID: 35788704
[TBL] [Abstract][Full Text] [Related]
10. Does a novel penalized likelihood reconstruction of 18F-FDG PET-CT improve signal-to-background in colorectal liver metastases?
Parvizi N; Franklin JM; McGowan DR; Teoh EJ; Bradley KM; Gleeson FV
Eur J Radiol; 2015 Oct; 84(10):1873-8. PubMed ID: 26163992
[TBL] [Abstract][Full Text] [Related]
11. Image quality and lesion detectability in low-dose pediatric
Zhao YM; Li YH; Chen T; Zhang WG; Wang LH; Feng J; Li C; Zhang X; Fan W; Hu YY
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3378-3385. PubMed ID: 33738519
[TBL] [Abstract][Full Text] [Related]
12. Total-body
Hu P; Zhang Y; Yu H; Chen S; Tan H; Qi C; Dong Y; Wang Y; Deng Z; Shi H
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2384-2394. PubMed ID: 33866409
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.
Herbrik M; Treffert J; Geiger B; Riegger C; Hartung V; Rosenbaum-Krumme SJ; Forsting M; Antoch G; Heusner TA
J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390
[TBL] [Abstract][Full Text] [Related]
14. The image quality, lesion detectability, and acquisition time of
Zhang YQ; Hu PC; Wu RZ; Gu YS; Chen SG; Yu HJ; Wang XQ; Song J; Shi HC
Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2507-2515. PubMed ID: 32424483
[TBL] [Abstract][Full Text] [Related]
15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
16. Application of the long axial field-of-view PET/CT with low-dose [
Sachpekidis C; Pan L; Kopp-Schneider A; Weru V; Hassel JC; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1158-1167. PubMed ID: 36474125
[TBL] [Abstract][Full Text] [Related]
17. Different hydration protocols for the quantification of healthy tissue uptake of half-dose
Cao Y; Cai D; Sui X; Wang X; Song J; Tan H; Hu P; Zhang Y; Yu H; Shi H
Quant Imaging Med Surg; 2023 Sep; 13(9):5701-5712. PubMed ID: 37711806
[TBL] [Abstract][Full Text] [Related]
18. Ultralow-dose [
Tan H; Qi C; Cao Y; Cai D; Mao W; Yu H; Sui X; Liu G; Shi H
Eur Radiol; 2023 Jul; 33(7):5017-5027. PubMed ID: 36688971
[TBL] [Abstract][Full Text] [Related]
19. [Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy].
Strunk H; Bucerius J; Jaeger U; Joe A; Flacke S; Reinhardt M; Hortling N; Palmedo H
Rofo; 2005 Sep; 177(9):1235-41. PubMed ID: 16123869
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
Deleau C; Buecher B; Rousseau C; Kraeber-Bodéré F; Flamant M; des Varannes SB; Frampas E; Galmiche JP; Matysiak-Budnik T
Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):275-81. PubMed ID: 21304319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
